Antidepressant Tapering Is Not Routine But Could Be

References

1. 1.↵
   1. Brody DJ,
   2. Gu Q

   . Antidepressant use among adults: United States, 2015–2018. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2020.
2. 2.↵
   1. Read J

   . How common and severe are six withdrawal effects from, and addiction to, antidepressants? The experiences of a large international sample of patients. Addict Behav 2020;102:106157.

   OpenUrl
3. 3.↵
   1. Henssler J,
   2. Heinz A,
   3. Brandt L,
   4. Bschor T

   . Antidepressant withdrawal and rebound phenomena. Dtsch Arztebl Int 2019;116:355–61.

   OpenUrlCrossRef
4. 4.↵
   1. Davies J,
   2. Read J

   . A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav 2019;97:111–21.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Jauhar S,
   2. Hayes J

   . The war on antidepressants: what we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read. Addict Behav 2019;97:122–5.

   OpenUrlCrossRefPubMed
6. 6.↵
   SurvivingAntidepressants.org [Internet]. Introductions and updates; 2022. Available from: https://www.survivingantidepressants.org/forum/3-introductions-and-updates/. Accessed July 9, 2022.
7. 7.↵
   OPERA: the Netherlands study of Optimal, PERsonalized Antidepressant use [Internet]. Psychiatry Amsterdam; 2022. Available from: https://psychiatryamsterdam.nl/project/opera/. Accessed July 7, 2022.
8. 8.↵
   1. Sørensen A,
   2. Juhl Jørgensen K,
   3. Munkholm K

   . Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review. Ther Adv Psychopharmacol 2022;12:20451253211067656.

   OpenUrl
9. 9.↵
   1. Horowitz MA,
   2. Taylor D

   . Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry 2019;6:538–46.

   OpenUrl
10. 10.↵
    1. Ruhe HG,
    2. Horikx A,
    3. van Avendonk MJ,
    4. Groeneweg BF,
    5. Woutersen-Koch H

    , Discontinuation of Antidepressants Taskforce. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry 2019;6:561–2.

    OpenUrl
11. 11.↵
    Quick Facts Oregon [Internet]. Washington, DC: US Census Bureau; 2022. Available from: https://www.census.gov/quickfacts/fact/table/OR/RHI125218. Accessed July 9, 2022.
12. 12.↵
    1. Lewis G,
    2. Marston L,
    3. Duffy L,
    4. et al

    . Maintenance or discontinuation of antidepressants in primary care. N Engl J Med 2021;385:1257–67.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Davies J,
    2. Read J

    . Authors' response to a critique by Jauhar and Hayes of “A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based?” Addict Behav 2019;97:127–30.

    OpenUrl
14. 14.↵
    1. Fava GA,
    2. Belaise C

    . Discontinuing antidepressant drugs: lesson from a failed trial and extensive clinical experience. Psychother Psychosom 2018;87:257–67.

    OpenUrl
15. 15.↵
    1. Hengartner MP

    . How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding. Ther Adv Psychopharmacol 2020;10:2045125320921694.

    OpenUrlPubMed
16. 16.↵
    1. Maund E,
    2. Stuart B,
    3. Moore M,
    4. et al.

    Managing antidepressant discontinuation: a systematic review. Ann Fam Med 2019;17:52–60.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Framer A

    . What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Ther Adv Psychopharmacol 2021;11:2045125321991274.

    OpenUrl